SEC Filing | Company/Stock | Trade Date | Transaction | Shares | Avg. Price | Total | % Holdings | Gain/Loss |
---|---|---|---|---|---|---|---|---|
24-May-22 5:14 PM View: | Phasebio Pharmaceuticals Inc (PHAS) | 20-May-22 | Grant | 10,918 | $0.68 | $7,438.43 | 6% 172.78K to 183.7K | |
23-Nov-21 6:55 PM View: | Phasebio Pharmaceuticals Inc (PHAS) | 19-Nov-21 | Grant | 5,623 | $2.01 | $11,302.20 | 3% 166.85K to 172.47K | |
03-Nov-21 7:30 PM View: | Phasebio Pharmaceuticals Inc (PHAS) | 03-Nov-21 | Option Exercise | 20,000 | $1.24 | $24,800.00 | 14% 146.85K to 166.85K | |
30-Aug-21 5:52 PM View: | Phasebio Pharmaceuticals Inc (PHAS) | 27-Aug-21 | Option Exercise | 20,000 | $1.24 | $24,800.00 | 16% 126.85K to 146.85K | |
24-May-21 6:10 PM View: | Phasebio Pharmaceuticals Inc (PHAS) | 20-May-21 | Grant | 3,964 | $2.80 | $11,099.20 | 3% 122.89K to 126.85K | |
23-Nov-20 6:34 PM View: | Phasebio Pharmaceuticals Inc (PHAS) | 20-Nov-20 | Grant | 3,643 | $3.00 | $10,929.00 | 3% 119.24K to 122.89K | |
24-Aug-20 7:04 PM View: | Phasebio Pharmaceuticals Inc (PHAS) | 21-Aug-20 | Option Exercise | 10,000 | $1.24 | $12,400.00 | 9% 109.24K to 119.24K | |
10-Sep-19 4:10 PM View: | Phasebio Pharmaceuticals Inc (PHAS) | 06-Sep-19 | Option Exercise | 19,000 | $1.24 | $23,560.00 | 21% 90.24K to 109.24K | |
21-May-19 6:27 PM View: | Phasebio Pharmaceuticals Inc (PHAS) | 20-May-19 | Option Exercise | 19,131 | $1.24 | $23,722.40 | 27% 71.11K to 90.24K | |
21-May-19 6:27 PM View: | Phasebio Pharmaceuticals Inc (PHAS) | 17-May-19 | Option Exercise | 19,913 | $2.27 | $45,202.50 | 39% 51.2K to 71.11K | |
17-Dec-18 4:18 PM View: | Phasebio Pharmaceuticals Inc (PHAS) | 13-Dec-18 | Purchase | 1,000 | $3.69 | $3,690.00 | 2% 50.2K to 51.2K | |
11-Dec-18 4:12 PM View: | Phasebio Pharmaceuticals Inc (PHAS) | 10-Dec-18 | Purchase | 800 | $3.85 | $3,080.00 | 2% 50.9K to 51.7K | |
11-Dec-18 4:12 PM View: | Phasebio Pharmaceuticals Inc (PHAS) | 07-Dec-18 | Purchase | 2,200 | $3.88 | $8,536.00 | 5% 48.7K to 50.9K | |
24-Oct-18 4:18 PM View: | Phasebio Pharmaceuticals Inc (PHAS) | 22-Oct-18 | Conversion | 310 | -- | -- | < 1% 45.19K to 45.5K | |
24-Oct-18 4:18 PM View: | Phasebio Pharmaceuticals Inc (PHAS) | 22-Oct-18 | Conversion | 3,505 | -- | -- | 8% 45.5K to 49.01K |